The HEOR capability within the pharmaceutical industry is at a tipping point.On one hand are two well-attended recent conferences (ISPOR-US and EU, 2024) with a total of over 10,500 attendees joining ...

There is increasing evidence that improving patient outcomes and cultivating value in the healthcare environment will require health economics and outcomes research (HEOR). Nicole Hengst ...

As local payers come under more pressure to constrain costs, the value of Health Economics and Outcomes Research (HEOR) is increasing. The involvement of market access teams at every stage of ...

Open Health has joined forces with health economics and outcomes research (HEOR) company Pharmerit International in a move that strengthens its existing market access capabilities. The integration ...

For decades, life sciences professionals have turned to Health Economics and Outcomes Research (HEOR) to assess the clinical and economic value of health technologies. But HEOR is evolving. The ...

Market Growth: The HEOR services market is expected to reach US$ 3.79 billion by 2031 from US$ 1.68 billion in 2024, at a CAGR of 12.3% during the forecast period. HEOR services encompass various ...

That’s where health economics and outcomes research (HEOR) plays a crucial role. Nick Li is global HEOR lead for hemoglobinopathies at Vertex Pharmaceuticals. Below he explains why this type of ...

Health Economics and Outcomes Research (HEOR) plays a critical role in informing healthcare decisions by assessing the value of medical treatments and interventions. By evaluating costs, clinical ...